Influence of Socio-aesthetic Care on the Quality of Life of Hemodialysis Patients
SocioAesthetic
1 other identifier
interventional
161
1 country
1
Brief Summary
The report of the Epidemiological and Information Network in Nephrology counted 44,978 hemodialysis patients in France in 2017, with more than 93% of them attending 3 sessions per week. This multi-weekly recourse to the healthcare system in the context of substitution treatment constantly reminds patients of their disease and has a strong impact on their quality of life. The 2011 REIN quality of life report showed that the quality of life of patients with renal failure, particularly dialysis patients, is impaired, particularly in its physical and mental components. A recent comparative study (van Sandwijk et al., 2019) comparing hemodialysis patients with hematological cancer patients under chemotherapy supports these data. The June 2013 report of the "Etats généraux du rein", an initiative of patient associations, called for the improvement of quality of life to be made a priority and for the possibility of using supportive care and complementary non-drug techniques to be proposed. Socio-aesthetic care, defined "as the practice of aesthetic care for people who are suffering or vulnerable", has found its place in hospitals as a complementary discipline to medical care, particularly in oncology. We believe that in order to improve the overall quality of life of hemodialysis patients, the quality of the experience of each session must be improved. In this perspective, the repetition of socio-aesthetic care performed during dialysis sessions could contribute to the overall improvement of the quality of life. A national survey (Saghatchian et al., 2018) on the impact of socio-aesthetic care in oncology confirms the positive perception of this care among cancer patients. Two studies carried out in hemodialysis (Bullen et al., 2018; Unal \& Balci Akpinar, 2016) using complementary techniques, such as acupuncture, massage, or foot reflexology, highlight an impact on sleep, fatigue and quality of life. The experience of implementing socio-aesthetic care in our hemodialysis unit also leads us to believe that they positively influence the perception of the session, and therefore perhaps the quality of life measured with a validated scale, the KDQOL (Kidney Disease Quality Of Life). Our research therefore focuses on the effectiveness of social and aesthetic care during hemodialysis sessions to improve the quality of life of the hemodialysis patient.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 3, 2021
CompletedFirst Posted
Study publicly available on registry
August 11, 2021
CompletedStudy Start
First participant enrolled
January 17, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 25, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 25, 2024
CompletedFebruary 10, 2025
February 1, 2025
2.4 years
August 3, 2021
February 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Scale of quality of life (KDQoL)
Quality of life is assess by using KDQoL from 0 (worse quality of life) to 100 (better quality of life)
Day 0
Scale of quality of life (KDQoL)
Quality of life is assess by using KDQoL from 0 (worse quality of life) to 100 (better quality of life)
At Month 1
Secondary Outcomes (2)
Scale of anxiety and depression (HADS)
Day 0
Scale of anxiety and depression (HADS)
At Month 1
Study Arms (2)
Experimental Arm
EXPERIMENTALControl arm
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- years of age or older;
- Suffering from chronic kidney failure
- On hemodialysis for 1 month
- Dialysed 3 times a week
- In heavy center ;
- fluent in French;
- Benefiting from a social security system;
You may not qualify if:
- Having cognitive problems hindering the comprehension of the tool.
- Under protection of justice (guardianship or curatorship).
- Patients allergic to the care products used
- Patients with additional precautions related to a high risk of cross-transmission such as emerging highly resistant bacteria, scabies, clostridium difficile, pulmonary tuberculosis.
- Patients in withdrawal from other dialysis centers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- CHU de Reimslead
Study Sites (1)
Damien JOLLY
Reims, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 3, 2021
First Posted
August 11, 2021
Study Start
January 17, 2022
Primary Completion
June 25, 2024
Study Completion
July 25, 2024
Last Updated
February 10, 2025
Record last verified: 2025-02